Aziyo BiologicsInc Performance
| AZYODelisted Stock | USD 1.65 0.15 10.00% |
The firm shows a Beta (market volatility) of 1.97, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aziyo BiologicsInc will likely underperform. Aziyo BiologicsInc right now shows a risk of 0.0%. Please confirm Aziyo BiologicsInc value at risk, as well as the relationship between the rate of daily change and relative strength index , to decide if Aziyo BiologicsInc will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Aziyo BiologicsInc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Aziyo BiologicsInc is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 30.4 M | |
| Free Cash Flow | -22 M |
Aziyo |
Aziyo BiologicsInc Relative Risk vs. Return Landscape
If you would invest 165.00 in Aziyo BiologicsInc on January 25, 2024 and sell it today you would earn a total of 0.00 from holding Aziyo BiologicsInc or generate 0.0% return on investment over 90 days. Aziyo BiologicsInc is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Aziyo, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aziyo BiologicsInc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aziyo BiologicsInc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aziyo BiologicsInc, and traders can use it to determine the average amount a Aziyo BiologicsInc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AZYO |
Based on monthly moving average Aziyo BiologicsInc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aziyo BiologicsInc by adding Aziyo BiologicsInc to a well-diversified portfolio.
Aziyo BiologicsInc Fundamentals Growth
Aziyo Stock prices reflect investors' perceptions of the future prospects and financial health of Aziyo BiologicsInc, and Aziyo BiologicsInc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aziyo Stock performance.
| Return On Equity | -7.75 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (0.70) % | |||
| Operating Margin | (0.50) % | |||
| Current Valuation | 40.69 M | |||
| Shares Outstanding | 11.92 M | |||
| Price To Book | 13.34 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 49.19 M | |||
| EBITDA | (22.38 M) | |||
| Cash And Equivalents | 16.49 M | |||
| Cash Per Share | 1.21 X | |||
| Total Debt | 34.89 M | |||
| Debt To Equity | 3.50 % | |||
| Book Value Per Share | (1.36) X | |||
| Cash Flow From Operations | (21.43 M) | |||
| Earnings Per Share | (2.18) X | |||
| Total Asset | 68.84 M | |||
| Retained Earnings | (137.99 M) | |||
About Aziyo BiologicsInc Performance
To evaluate Aziyo BiologicsInc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Aziyo BiologicsInc generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Aziyo Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Aziyo BiologicsInc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Aziyo's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic devicecardiovascular, orthopedicspinal repair, and soft tissue reconstruction markets. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland. Aziyo Biologics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 162 people.Things to note about Aziyo BiologicsInc performance evaluation
Checking the ongoing alerts about Aziyo BiologicsInc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aziyo BiologicsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aziyo BiologicsInc is now traded under the symbol ELUT. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Aziyo BiologicsInc is not yet fully synchronised with the market data | |
| Aziyo BiologicsInc may become a speculative penny stock | |
| Aziyo BiologicsInc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 49.19 M. Net Loss for the year was (32.9 M) with profit before overhead, payroll, taxes, and interest of 19.22 M. | |
| Aziyo BiologicsInc currently holds about 16.49 M in cash with (21.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.21. | |
| Roughly 70.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Aziyo BiologicsInc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aziyo BiologicsInc's stock is overvalued or undervalued compared to its peers.
- Examining Aziyo BiologicsInc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aziyo BiologicsInc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aziyo BiologicsInc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aziyo BiologicsInc's stock. These opinions can provide insight into Aziyo BiologicsInc's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Aziyo Stock
If you are still planning to invest in Aziyo BiologicsInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo BiologicsInc's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |